Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Minerva Chir ; 47(1-2): 1-10, 1992 Jan.
Article in Italian | MEDLINE | ID: mdl-1553046

ABSTRACT

The pheochromocytoma syndrome, caused by an abnormal secretion of catecholamines, is a rare pathology responsible for 0.1-2% cases of hypertension in the overall population considered. Although in the past we deemed the pheochromocytoma could cause prevalently the typical syndrome characterized by paroxysmal hypertensive crises, now we think that the usual clinical presentation is a continue or subcontinue hypertensive state (65%). In this paper the authors refer the clinical experience acquired in 25 years in the General and Cardiovascular Institute of the University of Milan (head: Prof. Ugo Ruberti), analyzing epidemiological aspects and pathogenesis of pheochromocytoma, with particular care to diagnostic methodologies and referring the therapeutic choices. From 1965 until today 40 patients have been surgically treated for pheochromocytoma mono or bilateral. 43 operations have been done, carrying out 46 adrenalectomy. Two complication must be referred: an ictus cerebri consequent upon an hypertensive crisis and one death caused by intraoperative ventricular fibrillation. Normalization of arterial pressure has been obtained in all patients.


Subject(s)
Adrenal Gland Neoplasms/diagnosis , Pheochromocytoma/diagnosis , Adrenal Gland Neoplasms/complications , Adrenal Gland Neoplasms/surgery , Adrenalectomy , Catecholamines/analysis , Humans , Hypertension/etiology , Hypertension/surgery , Pheochromocytoma/complications , Pheochromocytoma/surgery , Postoperative Complications/epidemiology
2.
Clin Ter ; 138(2): 83-6, 1991 Jul 31.
Article in Italian | MEDLINE | ID: mdl-1834404

ABSTRACT

In order to confirm the efficacy of ibopamine for the management of congestive heart failure, as shown by the disappearance of clinical symptoms, the authors have assessed the cardiothoracic index before and after drug administration. In the 17 female patients examined the index was markedly improved, i.e. from an average of 0.561 +/- 0.058 to an average of 0.538 +/- 0.052, (p less than 0.01). This finding, together with the disappearance of dyspnea and edema, confirms that there was a change in disease pattern and that treatment with this drug was effective.


Subject(s)
Cardiotonic Agents/therapeutic use , Deoxyepinephrine/analogs & derivatives , Heart Failure/drug therapy , Radiography, Thoracic , Vasodilator Agents/therapeutic use , Administration, Oral , Aged , Aged, 80 and over , Cardiotonic Agents/administration & dosage , Deoxyepinephrine/administration & dosage , Deoxyepinephrine/therapeutic use , Female , Heart Failure/diagnostic imaging , Humans , Middle Aged , Time Factors , Vasodilator Agents/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...